Navigation Links
Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
Date:7/28/2011

er clinical trial conducted at the Fred Hutchinson Cancer Research Center, which demonstrated statistical significance in its primary endpoint of controlling GI GVHD (p-value 0.02). The second study was a 129-patient pivotal Phase 3 multi-center clinical trial conducted at 16 leading bone marrow/stem cell transplant centers in the US and France. Although orBec® did not achieve statistical significance in the primary endpoint of its pivotal trial, namely median time-to-treatment failure through Day 50 (p-value 0.1177), orBec® did achieve statistical significance in other key secondary endpoints such as the proportion of patients free of GVHD at Day 50 (p-value 0.05) and Day 80 (p-value 0.005) and the median time to treatment failure through Day 80 (p-value 0.0226), as well as a 66% reduction in mortality among patients randomized to orBec® at 200 days post-transplant with only 5 patient (8%) deaths in the orBec® group compared to 16 patient (24%) deaths in the placebo group (p-value 0.0139).  At one year post-randomization in the Phase 3 trial, 18 patients (29%) in the orBec® group and 28 patients (42%) in the placebo group died within one year of randomization (46% reduction in mortality, p-value 0.04).

orBec® represents a first-of-its-kind oral, locally acting therapy tailored to treat the GI manifestation of acute GVHD, the organ system where GVHD is most frequently encountered and highly problematic.  orBec® is intended to reduce the need for systemic immunosuppressive drugs to treat GI GVHD.  orBec® is formulated for oral administration in GVHD patients as a single product consisting of two tablets; one tablet is intended to release BDP in the proximal portions of the GI tract, and the other tablet is intended to release BDP in the distal portions of the GI tract.  Oral BDP may also have application in treating other GI disorders characterized by severe inflammation.  

In addition to
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
2. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
3. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
4. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
5. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
6. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
7. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
8. Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT
9. Soligenix Announces Award of $1.2 Million FDA Orphan Products Development Grant
10. Soligenix to Present at the OneMedForum Conference on Wednesday, June 30 at 2PM EDT
11. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Actavis plc (NYSE: ACT ) announced today ... and Drug Administration (FDA) as a twice-daily, oral ... with diarrhea (IBS-D). VIBERZI (eluxadoline) has mixed opioid ... a delta receptor antagonist, and a kappa receptor ... "The FDA,s approval of VIBERZI is ...
(Date:5/27/2015)... Madison Laser Tattoo Removal is the first laser tattoo ... the surrounding area to offer treatments with the Astanza Duality. ... dedicated to bringing a solution to those living with tattoo ... "I founded Madison Laser Tattoo Removal to give patients a ... its natural look," said Emily Livesey, RN and ...
(Date:5/27/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences ... of innovative products and services, today announced that its ... operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier screen ... North Carolina laboratory location.  "The ...
Breaking Medicine Technology:Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 2Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 3Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 4Actavis Receives FDA Approval for VIBERZI (eluxadoline) for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D) in Adults 5Madison Laser Tattoo Removal Brings Superior Laser Tattoo Removal Services To Madison, WI With Astanza Duality 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3
... , , SAN FRANCISCO , Feb. ... Board: MZEI) announced today that every full scale test ... has resulted in the total elimination of all bacteria present ... Medizone,s scientific team will attempt to confirm, in a more ...
... NEW YORK , Feb. 4 Delcath Systems, Inc. ... treatment system for metastatic cancers to the liver, announced today that ... on its Phase III trial.  The trial uses the drug melphalan ... "We remain very optimistic that the Phase III trial will achieve ...
Cached Medicine Technology:AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs 2AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs 3Delcath Systems Begins Data Analysis of Phase III Trial 2Delcath Systems Begins Data Analysis of Phase III Trial 3
(Date:5/27/2015)... 27, 2015 In today's healthcare landscape, ... it can be challenging for doctors and hospitals to ... treatments. , Austin-based HealthTronics, Inc. is ... mobile medical therapies for clinically sophisticated applications. The company ... acquisition of Laser Ventures, Inc ., a mobile ...
(Date:5/27/2015)... 2015 Dr. Omar Ibrahimi, Dermatologist and ... CT has been selected as part of a controlled ... (and the only physician in Connecticut) to offer the ... the removal of submental fat (double chin). The procedure ... no surgery and minimal risks. Dr. Ibrahimi is an ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a leading ... announced today that SanMar Corporation successfully implemented the ... and point tracking processes for over 3,000 employees ... , Family-owned since 1971, Seattle-based SanMar Corporation is ... and mill brands. SanMar supplies apparel and accessories ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 In support ... April 2015 issue of the Journal of American Geriatrics ... and abdominal obesity, Bedford Commons OB-GYN P.A . ... of non-nutritive sweetener-flavored beverages. , To examine the ... a comprehensive San Antonio Longitudinal Study of Aging (SALSA) ...
(Date:5/27/2015)... AR (PRWEB) May 27, 2015 ... today announce a partnership to provide CMSA's Career ... community. This collaboration seeks to strengthen the case/care ... through CMSA’s CKP program. The mutually beneficial agreement ... identifying individual skills of talent in the healthcare, ...
Breaking Medicine News(10 mins):Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... tea extract has recently achieved GRAS (Generally Recognized As ... US a strong signal of the ingredient’s suitability in ... being used in a number of supplement products in ... Vitamin Shoppe and Healthy Origins, American food companies say ...
... that postmenopausal women would have lesser chance of losing their ... Their research was published in the latest issue of Journal ... had found that in an average of 11 years, at ... says that alveolar bone loss is one of the most ...
... South Wales may be one of the first scientists to ... there is no single test that could exactly identify the ... the latest issue of the journal Psychiatry Research said that ... cost effective as their tool can safely distinguish between the ...
... to be in slumber for the past 11 months, baffling doctors ... Arup Manna of Panskura in East Midnapore district was an active ... suddenly started falling asleep., ,The meritorious boy, who used to ... for feeding and answering nature's call., ,The boy's mother says ...
... of morbidity and mortality in India. An attempt to formulate// ... many young lives, is worth the expense., , India ... a new vaccine for a deadly form of diarrhoea that ... been accelerated after phase I clinical trials showed up to ...
... soy Z-Trim fat replacer at a recent show //in New ... a variety of products without altering the food's original taste. ... soy Z-Trim fat replacer at a recent show in New ... 55 symposia and 14,000 attendees. , ,According to the ...
Cached Medicine News:Health News:Yet Another Use For Green Tea Extract 2Health News:New Insight In Periodontal Disease In Postmenopausal Women 2Health News:Schizophrenia Gets A New Diagnostic Tool 2Health News:New Oat And Soy-Based Fat Replacer Launched 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: